GRIFFIN Trial Overview

Saad Usmani, MD, MBA, FACP, discusses the health-related quality of life (HRQoL) data from the GRIFFIN trial presented at ASH 2022 and reviews his key takeaways, including this thoughts on how healthcare decision-makers should act on these results.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences
All rights reserved.